rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2009-7-22
|
pubmed:abstractText |
Cyclooxygenase-2 (COX-2) inhibitors have been shown to exert chemopreventive effects against gastrointestinal carcinomas. This study was to investigate the effect of celecoxib, a selective COX-2 inhibitor, on the expression of E-cadherin and serum levels of soluble E-cadherin in gastric carcinomas.
|
pubmed:language |
chi
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1000-467X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
361-5
|
pubmed:meshHeading |
pubmed-meshheading:19622294-Adenocarcinoma,
pubmed-meshheading:19622294-Adult,
pubmed-meshheading:19622294-Cadherins,
pubmed-meshheading:19622294-Cyclooxygenase 2,
pubmed-meshheading:19622294-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:19622294-Female,
pubmed-meshheading:19622294-Humans,
pubmed-meshheading:19622294-Immunohistochemistry,
pubmed-meshheading:19622294-Male,
pubmed-meshheading:19622294-Middle Aged,
pubmed-meshheading:19622294-Preoperative Period,
pubmed-meshheading:19622294-Pyrazoles,
pubmed-meshheading:19622294-Stomach Neoplasms,
pubmed-meshheading:19622294-Sulfonamides,
pubmed-meshheading:19622294-Up-Regulation
|
pubmed:year |
2009
|
pubmed:articleTitle |
[Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues].
|
pubmed:affiliation |
Department of Gastroenterology, The First Hospital Affiliated Lanzhou University, Lanzhou, Gansu, 730000, PR China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|